静脉注射丙种免疫球蛋白致新生儿ABO溶血症加重1例
A Case of Neonatal ABO Hemolysis Aggravated by Intravenous Injection of Gamma Immunoglobulin
摘要: 1例以“发现皮肤黄染加重2天”之代诉入院的患儿,在给与蓝光照射退黄治疗后,黄疸消退不明显,于生后第10天给与静脉注射丙种球蛋白2.5 g/次,共使用2天,于生后第12天复查血常规示WBC:12.46 × 109,Hb:74 g/L,血红蛋白较前明显下降,送交叉配血发现患儿血与同血型的献血者血液无法配对,给予输注O型洗涤红细胞后血红蛋白上升,至121 g/L,治疗6天痊愈出院。该病例提示,大量输注丙种球蛋白有加重或导致溶血的可能,考虑输注丙球时应该慎重,对于临床上的任何用药或治疗手段,不应只关注其治疗作用,还应考虑其不良反应和并发症的发生。
Abstract: One case complained on behalf of “skin yellowing was found to be aggravated for 2 days”. After blue light irradiation, jaundice did not subside significantly. On the 10th day after birth, intravenous in-jection of 2.5 g/time gamma globulin was given for 2 days. On the 12th day after birth, blood rou-tine examination showed that WBC was 12.46 × 109. Hb was 74 g/l, and hemoglobin was signifi-cantly lower than that before. It was found that the blood of the child could not be matched with that of the blood donor of the same blood type by sending cross matching blood. After infusion of type O washed red blood cells, hemoglobin increased to 121 g/l, and recovered after 6 days of treatment. This case suggests that a large amount of gamma globulin infusion may aggravate or cause hemolysis, so we should be careful when considering gamma globulin infusion. For any clini-cal medication or treatment, we should not only pay attention to its therapeutic effect, but also con-sider the occurrence of its adverse reactions and complications.
文章引用:杨露, 张渊韬, 刘巧娟. 静脉注射丙种免疫球蛋白致新生儿ABO溶血症加重1例[J]. 临床医学进展, 2022, 12(7): 6484-6487. https://doi.org/10.12677/ACM.2022.127935

参考文献

[1] 杜雅琪. 丙种球蛋白不同时机治疗新生儿ABO溶血症的疗效分析[J]. 系统医学, 2021, 6(2): 111-113.
[2] 黄杰, 乾艾娜, 甘斌, 等. 不同时机丙种球蛋白治疗新生儿ABO溶血症的疗效[J]. 中国继续医学教育, 2020, 12(1): 131-132.
[3] 练惠敏. 大剂量丙种球蛋白早期应用治疗新生儿溶血症的临床效果观察[J]. 中国现代药物应用, 2018, 12(12): 116-117.
[4] 李茂军, 陈昌辉, 吴青, 等. 静脉注射丙种球蛋白治疗新生儿溶血症的系统评价[J]. 中国循证医学杂志, 2010, 10(10): 1199-1204.
[5] Delaney, M. and Matthews, D.C. (2015) Hemolytic Disease of the Fetus and Newborn: Managing the Mother, Fetus, and Newborn. Hematology, ASH Education Program, 2015, 146-151.
[6] 张慧慧, 刘蓓, 陈宇峰, 程可萍. 单次高剂量丙种球蛋白给药方式对新生儿ABO溶血症的临床疗效研究[J]. 中国妇幼保健, 2019, 34(24): 5652-5654.
[7] 吴桂娥, 梁世山, 王琦凡. 大剂量丙种球蛋白治疗新生儿溶血症的临床疗效[J]. 临床合理用药杂志, 2019, 12(15): 67-68.
[8] 冯乃超, 钟丽花, 胡玲. 单剂量静脉注射用人血丙种球蛋白治疗新生儿ABO溶血病疗效观察[J]. 陕西医学杂志, 2017, 46(11): 1592-1593.
[9] 黄华飞, 袁天明, 周向明, 等. ABO溶血病患儿应用丙种球蛋白的胆红素阈值探讨[J]. 中国新生儿科杂志, 2013, 28(4): 230-233.
[10] 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 第5版. 北京: 人民卫生出版社, 2019: 764-769.
[11] 夏兵, 韩杰, 朱晓晨. 静脉注射丙种球蛋白导致新生儿溶血性黄疸1例[J]. 中国输血杂志, 2011, 24(6): 523-524.
[12] 邱小兰, 钟昌瑞, 阙庆和, 等. 静脉注射丙种球蛋白导致新生儿交叉配血不合一例[J]. 中国新生儿科杂志, 2016, 11(5): 390.
[13] 章文, 吴跃平, 陈运生, 等. 患儿静脉输注丙种球蛋白后影响交叉配血4例[J]. 中国输血杂志, 2014, 27(3): 337-338.
[14] 胡玉莲, 夏世文. 新生儿ABO溶血病静脉用大剂量丙种球蛋白与坏死性小肠结肠炎的关系[J]. 中国新生儿科杂志, 2012, 27(5): 316-319.